President, API Development & Manufacturing
Stuart Needleman has more than 20 years' experience in drug development, with a specialization in the global development, scale-up, and manufacture of regulated active pharmaceutical ingredients (API) for new and established compounds. He currently has responsibility for the development of Aptuit’s API and Solid State Chemistry offering.
Stuart originally joined Aptuit as Senior Director of API Development. In December 2006 he became Vice President, Sales and Marketing, and after two years in this role was promoted to President of API Development and Manufacturing.
Stuart’s previous experience includes:
- Arch Pharmalabs – President, North America
- Cambrex
- Oxford Asymmetry (where he achieved a significant North American presence)
- ChiRexs Inc – Vice President, Business Development
- Rhodia Pharma Solutions - General Manager, Development Operations